קופגוס

Land: Ísrael

Tungumál: hebreska

Heimild: Ministry of Health

Virkt innihaldsefni:

RIBAVIRIN 200 MG

Fáanlegur frá:

ROCHE PHARMACEUTICALS (ISRAEL) LTD

ATC númer:

J05AB04

Lyfjaform:

TABLETS

Stjórnsýsluleið:

PER OS

Framleitt af:

HOFFMANN LA ROCHE, SWITZERLAND

Meðferðarhópur:

RIBAVIRIN

Ábendingar:

Copegus in combination with peginterferon alfa 2a or interferon alfa - 2a is indicated in adult patients who are positive for serum HCV-RNA, including patients with compensated cirrhosis . The combination with peginterferon alfa-2a is also indicated in patients co-infected with clinically stable HIV , including patients with compensated cirrhosis . Copegus, in combination with peginterferon alfa-2a, is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated) alone or in combination therapy with ribavirin.

Leyfisdagur:

2013-04-01